Neuromodulators determine how neural circuits process information during cognitive states such as wakefulness, attention, learning, and memory [1] . fMRI can provide insight into their function and dynamics, but their exact effect on BOLD responses remains unclear [2] [3] [4] , limiting our ability to interpret the effects of changes in behavioral state using fMRI. Here, we investigated the effects of dopamine (DA) injections on neural responses and haemodynamic signals in macaque primary visual cortex (V1) using fMRI (7T) and intracortical electrophysiology. Aside from DA's involvement in diseases such as Parkinson's and schizophrenia, it also plays a role in visual perception [5] [6] [7] [8] . We mimicked DAergic neuromodulation by systemic injection of L-DOPA and Carbidopa (LDC) or by local application of DA in V1 and found that systemic application of LDC increased the signal-tonoise ratio (SNR) and amplitude of the visually evoked neural responses in V1. However, visually induced BOLD responses decreased, whereas cerebral blood flow (CBF) responses increased. This dissociation of BOLD and CBF suggests that dopamine increases energy metabolism by a disproportionate amount relative to the CBF response, causing the reduced BOLD response. Local application of DA in V1 had no effect on neural activity, suggesting that the dopaminergic effects are mediated by long-range interactions. The combination of BOLD-based and CBF-based fMRI can provide a signature of dopaminergic neuromodulation, indicating that the application of multimodal methods can improve our ability to distinguish sensory processing from neuromodulatory effects.
Results
We combined fMRI with neurophysiology and pharmacology in five anesthetized nonhuman primates (Macaca mulatta), from which we acquired blood-oxygen-level-dependent (BOLD), functional cerebral blood flow (fCBF), and electrophysiology data while the animals viewed a rotating checkerboard stimulus. Figure 1A shows the experimental paradigm. We pharmacologically mimicked dopaminergic (DAergic) neurotransmission by systemic application of L-DOPA and Carbidopa (LDC). Carbidopa inhibits the breakdown of L-DOPA in the periphery, thereby preventing systemic changes in cerebral blood volume (CBV) that may affect the fMRI results (Figure S1 available online). The lack of systemic effects of the LDC injection is evidenced by the highly stable physiological parameters during and after injection (Table S1 ). Figure 1B shows representative fMRI responses in primary visual cortex (V1) to visual stimulation. Figure 1C shows the changes in the BOLD response over the course of the LDC injection. BOLD modulation in the predrug period was 2.5% 6 1.1%, which is typical for anesthetized monkeys at 7T [9] [10] [11] . During the drug infusion, we observed a significant reduction in the visually induced modulation (Figures 1C and 1D ; MOD drug = 50% 6 5.3%; p = 0.034), which was sustained after the infusion was stopped (MOD post = 60% 6 4.2%; p = 0.05). No significant changes in the baseline were found ( Figure 1D ).
Evoked BOLD and Neural Responses under Systemic LDC
We recorded local field potentials (LFPs) and multiunit spiking activity (MUA) to evaluate the effects of LDC application on neural activity. The power in the following three different frequency ranges was calculated: g (40-150 Hz), MUA (900-3,000 Hz), and q (4-8 Hz). g and MUA ranges were most strongly correlated with the BOLD signal [2, 3, 12] , whereas q was used to indicate whether LDC affects the broadband-LFP power and to assess whether dopamine (DA) injection induces changes in the level of anesthesia. Figures 2A-2C show the average time course across experiments for the q, g, and MUA bands, respectively. LDC application resulted in an 18% increase in visual modulation in the g band ( Figure 2D ; MOD g,drug = 118% 6 4.2%; p = 0.024) and a 19% increase in the MUA band (MOD MUA,drug = 119% 6 5%; p = 0.031). The effect of LDC on the MUA amplitude reached baseline values w4.5 min after the infusion was stopped. In contrast, for the g band, the increase in visually induced modulation was long lasting and started to reduce w12 min after the infusion was stopped. Additionally, we observed an increase in the signalto-noise ratio (SNR) of the g and MUA bands starting shortly after LDC injection ( Figure 2E) ; the response to the stimulus increased, whereas the variability decreased ( Figures 2B and  2C ). The SNR in the g band (SNR g,drug = 13.7 dB 6 2.0 dB; p = 0.011) kept increasing after the infusion was stopped (SNR g,post = 14.7 dB 6 2.0 dB; p = 0.012). The MUA band also showed an SNR increase after the start of the injection (SNR MUA,drug = 12.2 dB 6 2.2 dB; p = 0.012), which continued until the end of the trial (SNR MUA,post = 11.0 dB 6 2.0 dB; p = 0.026). In the q band (Figure 2A ), neither visually induced modulation nor SNR changed upon LDC infusion.
DA Effects Are Not Locally Induced in V1
We next investigated whether the increases in neural activity are locally induced in V1 or are due to a remote influence from other regions by injecting DA intracortically in V1 to determine whether this induces similar effects as systemic DA. Figures 3A-3C show the averaged traces of the q, g, and MUA bands during intracortical application of DA (5 mM) and show no discernible changes. Visually induced modulation in the g and MUA bands ( Figure 3D ) was unchanged (p = 0.23). The SNR of the g and MUA bands also remained unchanged during the experimental session ( Figure 3E ; SNR g,drug = 9.0 dB 6 1.5 dB; p = 0.31; SNR g,post = 8.8 dB 6 2.0 dB; p = 0.13; SNR MUA,drug = 10.1 dB 6 0.5 dB; p = 0.18; SNR MUA,post = 10.8 dB 6 2.0 dB; p = 0.18). Because different concentrations of DA can exert multiple modes of action [13] , we tested whether different concentrations of intracortical DA affected the responses in V1. However, no concentration-dependent effects were observed ( Figure S2 ).
The Effects of LDC on CBF Suggest an Increase in Energy Expenditure
Stimulus-induced increases in g power and in MUA occurred simultaneously with a decrease in BOLD modulation. To resolve this potential discrepancy, we measured fCBF using arterial spin labeling (ASL). Figure 4A shows fCBF in early visual cortex, and Figure 4B shows the averaged time course of the CBF across experiments. There was a reliable, visually induced CBF modulation of 19% 6 7% during the predrug period, in agreement with earlier studies [11] . During the ''drug'' period, we observed an increase in modulation by 34% (MOD drug = 134% 6 10%; p = 0.045). The maximum CBF increase of 43% was observed w12 min after the infusion started and lasted w20 min (MOD post = 143% 6 10%; p = 0.034). We also observed significant increases in baseline CBF during and after the injection. An increase in the baseline was evident w8 min after the start of the injection (CBF baseline,drug = 128% 6 5.2%; p = 0.022). The time course of the CBF changes upon LDC injection were similar to the time courses of the changes in the neuronal responses, suggesting that increases in neural activity may cause the CBF increases.
Discussion
Using BOLD-based and CBF-based fMRI combined with intracortical electrophysiology, we found that DAergic neuromodulation increased neural and CBF responses to a visual stimulus, whereas it decreased the BOLD response. Neuromodulators can exert strong influences on neural responses and alter neurovascular coupling [1, 3] . Our results show that changes in the BOLD fMRI signal alone cannot be used to make inferences about increases or decreases in the underlying neural activity.
Neurophysiological Effects of DA Injection
Neurophysiological recordings under systemic LDC injection showed an increase in the amplitude and SNR of visually evoked responses. DA has been shown to improve the SNR in prefrontal cortex (PFC) and in sensory areas, including V1 [8, [14] [15] [16] , thereby changing detection performance at the behavioral level [8, [16] [17] [18] . Increased neuronal activity in V1 has been shown to predict the timing of reward delivery, even when the cells were not driven by a visual stimulus [8, 18] , highlighting the importance of DA for extracting behaviorally relevant information [17, 19] .
However, local dopamine application did not change neural activity, in good agreement with the low density and sparse distribution of dopamine receptors (DARs) in V1 [20] , suggesting that DA does not exert its effects on V1 itself. The increase in neural activity upon systemic DA may be mediated by longrange interactions from higher-order regions (e.g., frontal regions) [5, 15] . Large-scale interactions have been reported in other sensory modalities, including the visual, somatosensory, and auditory systems, suggesting that DA prepares the higherorder area for the processing of incoming sensory signals and promotes the readout of task-related information [14] [15] [16] . Manipulation of prefrontal D1 receptors increased the magnitude, reliability, and selectivity of neuronal responses in V4 [5] , and similar mechanisms may play a role in V1.
The lack of DAergic effects upon local application is contrary to the inhibitory responses observed earlier [21, 22] . Although DA can exert different actions depending on concentration [13] , none of the DA concentrations used in this study changed the amplitude or SNR of the visually evoked responses. Aside from species differences [20, 23] , another possibility that could explain the differences is that the earlier experiments were performed with solutions in which the pH was not tightly controlled, whereas acidic pH depresses neuronal excitability [24] .
Functional Imaging
Our finding of a decrease in the evoked BOLD response and an increase in the CBF response upon systemic LDC injection extends previous observations in humans and macaques in which fMRI responses in V1 decreased with cues that predict and anticipate reward [6, 19] . A decrease in BOLD responses in V1 while behavioral performance improved after an acute dose of L-DOPA was seen in studies of amblyopia [7, 25] . However, BOLD increases have also been observed in humans in primary auditory and somatosensory cortex after DA agonist administration [26, 27] . These differences in BOLD responses upon DAergic neuromodulation can be partly explained by the difference in densities of DARs and DA innervation between cortical regions. DARs and DA innervations decrease along a rostral-caudal gradient, having the highest density in PFC and the lowest (or almost nonexistent) in occipital cortex [20] . Thus, BOLD responses to DAergic neuromodulation could differ in various sensory cortices because local influences of DA on the vasculature may modulate the blood supply [28, 29] .
The effects of DA on the hemodynamic signals have been extensively addressed using different pharmacological agents in rats and monkeys [29] [30] [31] [32] [33] . For instance, amphetamines decreased CBV responses in occipital regions [33] . However, amphetamines are known to increase DA levels as well as alter the kinetics of other neurochemicals that affect the regional CBV [34] , whereas CBV responses may differ from BOLD responses [35] . Different DARs exert different effects on the hemodynamic signals [30] ; stimulation of D1 receptors (D1Rs) increases CBV and BOLD responses [30, 32] , whereas blocking these receptors decreases them [30, 36] . The activation and deactivation of D2 receptors (D2Rs) produce opposite effects [37] . The present study did not consider receptor-specific responses but instead focused on understanding the balanced effects mediated by D1R and D2R interaction.
Neurovascular Coupling under Dopamine
Changes in the LFP are usually mirrored by changes in spiking and in the haemodynamic responses [3, 12] . Our observation of a dissociation between the BOLD and neurophysiological responses indicates that neurovascular coupling may differ under states of neuromodulation. Our results suggest that the increase in neural activity and CBF and the decrease in BOLD signal are caused by a disproportionate increase in O 2 consumption due to DAergic neuromodulation. The BOLD signal reflects the deoxyhemoglobin concentration (dHb concentration) and is affected by CBF, CBV, and the cerebral metabolic rate of oxygen consumption (CMRO 2 ). The stimulus-evoked BOLD decrease could be due to a CBF decrease or a dHb concentration increase after dopamine application. Because CBF increased, dHb production most likely also increased, i.e., an increase in CMRO 2 . An increase in CBF modulation and a decrease in BOLD response can occur when the O 2 consumption increases by a proportionally larger amount than the inflow of fresh blood, leading to a relative increase in dHb concentration and a decrease in the BOLD signal compared to the preinjection response.
The increased neural activity also suggests a CMRO 2 increase because it has been shown that improving neurons' sensitivity is energetically draining [17, 38] . Autoradiography has also shown that the application of L-DOPA increases brain metabolism [39] . These observations are not surprising given that energy usage is tightly coupled to neural performance [3, 38] . The increase in CBF likely relates to neural activity because glucose metabolism, CMRO 2 , and CBF are closely coupled [3, 40] . Increased neural activity in response to reward increases has been shown to increase the CBF [41] .
The increased baseline CBF upon acute LDC injection commonly seen in humans and nonhuman primates [42] [43] [44] is usually attributed to vasodilation. However, the stimulus-induced CBF increases cannot be attributed to vasodilation alone. Vasodilation increases the baseline CBF and BOLD signals and reduces stimulus-evoked CBF and BOLD signals due to limited reserves, as seen in the case of hypercapnia (a potent vasodilator) [45, 46] . The possibility that the BOLD reduction is due to a ceiling effect, as seen in the case of hypercapnia or in pathology, is therefore unlikely because evoked CBF decreases in the case of vasodilation (e.g., in hypercapnia) or an inadequate CBF response [47] .
Positron emission tomography studies have shown little or no change in CMRO 2 upon L-DOPA administration [43] , the latter reflecting little or no change in baseline response, as was observed here. A lack of CMRO 2 increase, however, would not be able to explain our stimulus-driven results: comparing them again with hypercapnia, where CMRO 2 and neural activity do not change considerably, this would lead to very different CBF and BOLD responses to the stimulus than observed here [45] . Whether the increase in baseline CBF corresponds to an increase in metabolism cannot be deduced based on the current data. The baseline of the BOLD time course did not change, with a minor tendency to go down. It is possible that the increase in CBF is balanced out by an increase in dHb concentration in the baseline state, leading to little or no net baseline changes. Following the same reasoning as with the stimulus-induced responses, the small decrease in the baseline BOLD trace may indicate a small increase in CMRO 2 in the baseline condition as well. However, further study is needed to verify this.
The effects observed here are unlikely to be due to DA-induced changes in the level of anesthesia because no differences were observed in the q band or the physiological parameters. The advantage of using anesthetized animals is that we could assess the effect of dopamine on neural and hemodynamic properties without needing to take behavioral parameters like attention, reward, and anticipation into account. Anesthetized animals also allow us to discriminate small changes because the anesthetized model allows for longer averaging times and higher SNR. However, differences in regional CBF under DAergic influence have been observed between awake and anesthetized animals [42] , and differences may depend on the type of anesthesia. Because neuromodulatory properties strongly depend on the animal's behavioral state, including its level of alertness, this highlights the complexity of fMRI studies of neuromodulation, and it would be ideal to have a comparison of dopaminergic effects in awake and anesthetized animals.
The findings presented here provide us with a better understanding of the influence of neuromodulation on fMRI signals. The decrease of the BOLD signal in the face of increased energy use implies that the BOLD response may not always faithfully reflect the neural responses under neuromodulation and that caution is necessary in interpreting BOLD signals under neuromodulation. Combining BOLD measurements with CBF and/or CBV measurements can resolve these complexities and potentially provide a tool to discriminate sensory processing from neuromodulation. Such multidisciplinary approaches may improve the interpretation of fMRI studies where neuromodulation plays a role, for example, in studies of reward or attention, and also facilitate clinical applications of fMRI.
Experimental Procedures
fMRI and electrophysiology data were collected from six (four females) healthy rhesus monkeys (Macaca mulatta; 5-11 kg, 6-12 years old). All experimental procedures were carried out under approval of the local authorities (Regierungsprä sidium, Baden-Wü rttemberg, Tü bingen, Germany, Project KY4/09) and were in full compliance with the guidelines of the European Community (EUVD 86/609/EEC). 
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